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TRPM8 is a cation channel expressed in a small subpopulation of sensory neurons, which 
detect innocuous cooling and mostly lack characteristics of nociceptors. Whether TRPM8 
normally contributes to noxious cold sensing is debatable as few TRPM8-positive neurons 
co-express nociceptive markers. TRPM8 is a promising analgesic target. TRPM8 agonists 
cause analgesia in chronic pain states, by TRPM8-expressing afferents gating-out a wide 
range of hypersensitive pain responses in spinal cord. TRPM8 antagonists may attenuate 
exaggerated responses to mild cooling during chronic pain but will not achieve generalised 
analgesia as they can only block cool detection, not the clinically problematic 
hypersensitivity to other sensory modalities. Biochemical and physiological properties of 
TRPM8, the chemistry of TRPM8 ligands, intracellular modulation of TRPM8 and the 
neurobiological consequences of TRPM8 activation are discussed, with a view to future 
improvements in therapeutic targeting. 
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Only just over ten years ago, the TRPM8 channel was cloned by several independent groups 
as the mediator of cool and menthol responsiveness in sensory ganglia and as unknown 
transcript from prostate that was upregulated in cancer 1-­‐3. Since that time, evidence has 
steadily and consistently accumulated to confirm a key physiological role of TRPM8 in the 
detection of innocuous cool. In addition there is increasing interest in the channel as a 
potential target for new analgesics, especially in the context of chronic pain states that 
respond poorly to currently available therapeutics.   
TRPM8 structure: 
The TRPM8 channel is a non-selective cation channel assembled as a homotetramer of the 
1104 amino acid protein, which individually has a molecular weight of around 128 kDa. The 
monomer has extended intracellular N- and C-termini and six transmembrane domains with a 
loop between domains 5 and 6 that is thought to contribute to the channel pore. Various 
reports implicate the C- or N-terminal segments in subunit assembly 4-­‐6. The C-terminal 
segment contains a short TRP box motif that is highly conserved throughout the family; 
including residues 1005 and 1009, involved in binding the allosteric potentiator PIP2 
(phosphatidylinositol 4,5-bisphosphate), and is also necessary for agonist responsiveness and 
setting the cool temperature response threshold 2,	   3,	   7-­‐9. The initial part of the N-terminal 
segment has also been implicated in moderating responsiveness to cool and menthol 10. 
Chemical agonists that activate TRPM8 include menthol and the synthetic compound icilin, 
both of which evoke a sensation of coolness. However differences in channel residues 
involved in their recognition indicate that the two agonists bind to distinct sites, consistent 
with evidence that activation by icilin or cooling but not by menthol shows clear pH 
dependence and that icilin but not menthol action appears to require an increase in 
intracellular Ca2+ levels 11,	   12. Mutation of residues 745, 842 and 856 in transmembrane 
domain 2 and the loop between domains 4 and 5 disrupts menthol activation whereas residues 
799, 802 and 805 in transmembrane domain 3 are required for icilin effects 12-­‐15.  TRPM8 
also shows voltage sensitivity, with residues 842 and 856 probably contributing to voltage 
sensing 14,	   16,	   17. Interactions between the different modes of activation are observed in that 
agonists not only increase open probability and conductance of the channel but also shift both 
its thermal threshold and voltage sensitivity towards more normal physiological levels 14,	  16-­‐19.  
The overall responses of a cell expressing TRPM8 to its activating stimuli will be further 
influenced by the effects of other ion channels on membrane potential and by signals from 
other receptors/intracellular signalling cascades.           
Localisation of TRPM8 in the nervous system: 
TRPM8 has a highly selective tissue distribution. Apart from primary somatosensory neurons 
and prostate tissue, from where it was cloned, it is expressed at only low levels in other 
tissues. These include visceral afferents, bladder, vascular smooth muscle, stomach, liver, 
colon, lung and airways, sperm and some primary tumours 20-­‐28. In the nervous system 
TRPM8 is strongly expressed in trigeminal (TG) and dorsal root ganglia (DRG) and has 
subsequently been observed in autonomic ganglia 29-­‐31. However, there appears to be 
extremely limited TRPM8 expression within the central nervous system (CNS) 32 other than 
that associated with afferent terminals. This idea was fully corroborated by observations on 
mutant mice expressing Green Fluorescent Protein (GFP) under the control of the TRPM8 
promoter 33,	  34. Furthermore, only 5-10% of DRG and TG neurons display the responsiveness 
to mild cooling (threshold around 25 oC), menthol and icilin that is characteristic of TRPM8, 
emphasizing the highly selective outcome to be expected from any intervention that might 
usefully target the channel. Early observations indicated that these neurons were small in 
diameter and distinct from those expressing classical nociceptive markers such as calcitonin 
gene-related peptide, TRPV1 or binding sites for the lectin IB4 3.  Most TRPM8-positive 
sensory neurons appear to be C-fibres staining for peripherin, with a minor group of Aδ 
fibres, whose small cell bodies stain for neurofilament antigens 2,	   33-­‐36. Extensive in situ 
hybridisation experiments in DRG indicated a pattern of cellular expression almost entirely 
distinct from that of the nociceptive channels TRPV1 and TRPA1 37. Other studies 
combining immunohistochemical and alternative localisation techniques indicate a modest 
degree of overlap 33,	   34,	   38, and our own dual immunofluorescence data from TRPM8 and 
TRPV1 (Table 1) concur in finding TRPV1 expression in a very small proportion of TRPM8-
positive cells.  A recent study utilising genetically targeted ablation of TRPV1 and TRPM8-
expressing cells reinforced the idea of minimal overlap 39. Technical issues such as 
differences in sensitivity and selectivity of the reagents and methods used may contribute to 
the range of findings reported.  A further factor to consider is that the extent of overlap may 
differ between somatic and autonomic sensory neurons where phenotypic subdivisions may 
differ from those of somatic afferents 20,	   24,	   40. Studies exploring functional responses of 
TRPM8 have also tried to explore the extent to which any overlap is significant.  
In vitro studies on the physiological role of TRPM8 in sensing cool / cold temperatures: 
When cloned TRPM8 is expressed in oocytes or fibroblasts, the cells are reported to show a 
temperature activation range from around 22-25 oC (threshold) to 8-10 oC (maximal) 2,	   3. 
Correspondingly, native TG neurons that show Ca2+ elevation responses selectively to 
menthol have thermal activation thresholds around 25 oC 41. DRG or TG neurons from 
TRPM8-/- mice show significantly reduced responses to cooling stimuli, which ranged in 
different studies from 22 oC through to 9 oC, and in C-fibre firing induced by cooling from 32 
oC to 2 oC in a skin-nerve preparation 42-­‐45. With such read-outs of responses to imposed 
progressive cooling, it is not clear whether components of responses in the noxious 
temperature range are lacking in TRPM8-/- mice as well as those from innocuous 
temperatures. These data remain equivocal in deciding whether TRPM8 is involved in 
physiological cold pain under normal conditions.  
A number of studies on cultured TG or DRG cells describe subpopulations responding to 
both mild cooling (generally through the range 25-17 oC) and to menthol that are considered 
to reflect TRPM8-expressing cells 46-­‐49. Some caution is needed though as menthol has only 
modest selectivity for TRPM8 over TRPA1 50, which also displays sensitivity to reduced 
temperatures and is expressed in a subset of TRPV1-positive nociceptors 41,	   51. A careful 
comparison of the temperature sensitivity of individual menthol-responsive / allyl 
isothiocyanate (TRPA1 agonist)-unresponsive TG neurons, likely to express TRPM8, and 
those activated by both menthol and allyl isothiocyanate, likely to express TRPA1, points to 
higher (innocuous range) temperature thresholds in the TRPM8 group but with substantial 
overlap 41.  
Although menthol-responsiveness in itself does not decisively implicate TRPM8, some 
studies have explored responsiveness of sensory neuron populations to menthol and capsaicin 
48. Neurons with dual responsiveness could be taken as evidence for functionally significant 
TRPM8 channels in nociceptors, but the debate remains equivocal because of menthol’s 
limited selectivity for TRPM8 over TRPA1. In addition, the electrophysiological responses of 
menthol-activated (putative TRPM8-positive) DRG neurons to mild cooling to 24 oC, 
involving tetrodotoxin-sensitive Na+ channels, appeared to be attenuated at the more intense 
cold level of 10 oC, whereas the intense cold-induced firing in neurons with tetrodotoxin-
insensitive Na+ channels (putative nociceptors) remained robust 52.  
The development of highly selective agonist and antagonist tools for TRPM8 should help to 
further elucidate the situation. An additional variable in experiments with cultured sensory 
neurons is the possibility of a change in phenotype relating to duration in vitro 34, a parameter 
that can differ considerably between studies, and may also undergo some transition during 
chronic pain states 53.  
In vivo studies on the physiological role of TRPM8 in sensing cool / cold temperatures: 
C-fibre recordings in rodents identify two distinct populations of cold-sensitive neurons 54. 
The first of these comprises low temperature threshold, mechano-insensitive, heat-insensitive 
afferents, sensitive to small reductions in skin temperature of as little as 2 oC, that are 
activated by menthol (10% topical) and by evaporative cooling due to acetone; ie non-
nociceptive thermoreceptors that may express TRPM8. The second comprises high threshold 
cold-, mechano- and heat-sensitive nociceptive afferents, firing at 12 oC or below that are 
indifferent to menthol. These findings are consistent with a significant role for TRPM8 in 
innocuous cool detection but not cold pain in normal animals. Similar profiles are reported 
from microneurography experiments in normal human volunteers 55. Very high 
concentrations of menthol (up to 40 %) applied topically to the skin are perceived as noxious 
56-­‐58; a situation mirrored by behavioural experiments in rodents 36, but interpretative caution 
is needed as TRPM8 selectivity is uncertain at such concentrations. In the special 
circumstance of the cornea, highly sensitive cool thermoreceptors predominate, which 
respond vigorously to small reductions in temperature (as little as 0.5 oC reduction) and 
contain abundant TRPM8 59.  
Thermal place preference tests with TRPM8-/- mice indicate lack of sensation across the 
innocuous cooling temperature range 42-­‐44,	   60. While colder temperatures (10 oC and below) 
showed return of temperature preference and cold plate paw withdrawal responses (10 oC and 
below) were normal in TRPM8-/- mice 42,	   44,	   45, some attenuation of thermal preference was 
seen, to a greater or lesser extent, at temperatures as low as 5 oC. Correspondingly, the 
flicking responses due to evaporative cooling from acetone, which can cool the skin to 
temperatures around 14-18 oC 43,	  61, were substantially reduced in TRPM8-/- mice 42,	  44 or by 
systemic administration of the high affinity TRPM8 antagonist PBMC 61. As this temperature 
range corresponds to the loosely-defined border between innocuous and noxious cooling in 
man 62 and the precise thermal consequences of differing laboratory protocols are uncertain, it 
is not clear that the test explicitly reflects cold pain as opposed to a response to innocuous 
cooling.  
Intraplantar injection of the selective TRPM8 agonist icilin at high local concentrations (8 
mM solution) can evoke flinching behaviour and spinal cord c-Fos expression, which are 
reduced in TRPM8-/- mice 43-­‐45,	   63. Intraplantar injections of icilin or menthol at high 
concentrations however cause activation of a wide variety of sensory neurons of different 
types through apparently TRPM8-independent processes 64. Furthermore, many agents when 
injected directly into the skin, presumably adjacent to sensory nerve terminals, can elicit 
nociceptive responses that they would not normally cause through other routes such as topical 
administration 65. While intraplantar icilin-evoked nocifensive behaviour appears to involve 
TRPM8, it is not clear that this relates to physiological cold sensing. 
As adaptive compensatory responses are possible in constitutive knockout animals, a targeted 
ablation strategy has also been investigated. In TRPM8 neuron-ablated mice (which express a 
diphtheria toxin (DTx) receptor transgene under the control of the TRPM8 promoter and 
were treated with DTx) results corroborated those in TRPM8-/- mice 39,	   60. TRPM8 ablation 
abrogated behavioural responses to acetone-induced evaporative cooling and thermal 
preference through the innocuous cooling range of 30-10 oC 39,	  60. However, avoidance of 0-
10 oC cold surfaces and paw withdrawal/flinching to severe noxious cold were also 
attenuated in TRPM8 neuron-ablated mice and this was to a greater extent than in TRPM8-/- 
mice 39,	   60. Some of these data were obtained with a new sensitive forepaw-flinching assay 
but the precise extent of temperature reduction reached in the forepaws may be affected by 
guarding behaviour. Furthermore because the strategy ablates neuronal populations rather 
than individual candidate molecular mediators, additional proteins in subsets of TRPM8-
expressing cells could be key to noxious cold sensing.  
Setting of thermal sensitivity in TRPM8-expressing sensory neurons: 
Pre-exposure to chemical agonists such as menthol markedly increases cold-induced Ca2+ 
entry in TRPM8-expressing oocytes or fibroblasts and menthol-sensitive TG cells, as well as 
cold-induced firing in a skin-nerve preparation 2,	   3,	   66, a phenomenon also reported with 
TRPA1 67. The effective temperature threshold for cellular responses to cooling can also be 
influenced by co-expressed K+ channels acting to hyperpolarise the membrane and oppose 
TRPM8-mediated depolarisation. Both Kv1 and Kv7 family channels are co-expressed with 
TRPM8, notably in nociceptors where high K+ channel : modest TRPM8 expression ratios 
may drive the cold threshold into the noxious temperature range 66,	   68. In contrast, low 
threshold non-nociceptive cool-sensing afferents appear to have high ratios of TRPM8 : K+ 
channel expression 59,	   66,	   68. In addition, K2P TREK family channels, some of which are 
directly closed by temperature reductions, are present in subsets of TRPM8-positive cells 69 
and may impact on their thermal sensitivity. Effects of cooling on A-type K+ channels and 
tetrodotoxin-sensitive or resistant Na+ channels may also modulate firing in cool 
thermoreceptors and cold nociceptors 52,	  70, while the notable resistance of Nav1.8 to cooling-
induced desensitisation is crucial for transmission in cold-sensitive afferents 71. TRPM8 
function (and indeed that of any other threshold-setting channels) is of course also subject to 
a variety of modulatory influences from intracellular signalling events (see below). 
The impact of pain states on TRPM8 function: 
Chronic pain states of either inflammatory or neuropathic origin crucially involve central 
hypersensitivity that is brought about by neurochemical changes ensuing from maintained 
nociceptor firing 72. This will manifest as exaggerated responses to noxious stimuli 
(hyperalgesia) and perception of normally innocuous stimuli as noxious (allodynia). This 
central re-setting of excitability will most likely apply to thermal, mechanical and cool 
sensory inputs so in the case of TRPM8-mediated inputs a degree of cool allodynia would be 
entirely expected. Whether there are any specific adaptive responses in TRPM8-expressing 
neurons themselves has been investigated by a number of groups, with varying results. There 
is little evidence that inflammation alters TRPM8 expression but there is clearly amplified 
responsiveness to acetone-induced cooling in the intraplantar Complete Freund’s Adjuvant 
(CFA) model of inflammatory pain 43. This could potentially reflect increased expression of 
TRPA1 73,	   74 or simply the expected central hypersensitivity to inputs from the TRPM8-
mediated innocuous cool afferents 60,	   61.  In some neuropathic pain models, TRPM8 
expression is reported to increase 36,	   75-­‐77, although little change, or reduced expression, has 
been reported in others 73,	   78,	   79. Cool allodynia is apparent after nerve injury and both 
pharmacological and genetic interventions indicate that this is likely to involve TRPM8 43,	  60,	  
61,	   76-­‐78. This may however reflect simply the TRPM8-mediated reportage of innocuous 
cooling that, like any other somatosensory input, becomes amplified due to injury-induced 
central sensitisation. Indeed a recent electrophysiological study reported that acetone-evoked 
evaporative cooling responses, but not other sensory responses of spinal cord neurons were 
inhibited by a selective TRPM8 antagonist in nerve injured but not naive rats 80. Interestingly 
however, in patients with established cool allodynia due to nerve injury, the topical 
administration of menthol does not aggravate hypersensitivity 81. 
TRPM8-mediated analgesia: 
Although cooling and mint extracts containing menthol have been widely used for many 
years due to their soothing, antinociceptive effects, the molecular basis was long unknown 82-­‐
85. The cloning of TRPM8 and its identification in a subset of DRG/TG sensory neurons 
provided a likely framework. In 2006, TRPM8 was specifically demonstrated for the first 
time to mediate analgesia due to cooling or the chemical agonists menthol and icilin, applied 
topically or intrathecally in animal models of both chronic neuropathic pain (CCI, chronic 
constriction injury) and inflammatory pain 36. The pharmacological identification of TRPM8 
mediation was corroborated by antisense knockdown experiments indicating that active 
functional TRPM8 was required as opposed to any potential for an effect due to agonist-
induced channel desensitisation. Both thermal (heat) hyperalgesia and mechanical allodynia 
were reversed, but cool allodynia was not addressed because of the likelihood of a complex, 
mixed influence. Interestingly, there was no effect on unsensitised responses in naive animals 
or in unaffected limbs until much higher concentrations, which produced pro-nociceptive 
effects. Experiments investigating the effects of relatively high concentrations of topically 
applied menthol in naive animals report attenuation of noxious thermal responses, mixed 
effects on cool/cold responses and sensitisation of innocuous mechanical responses 86, 
although mediation by TRPM8 was not ascertained and off-target effects may contribute. The 
original observations of TRPM8 analgesia were subsequently confirmed in the CCI model of 
neuropathic pain, where intrathecal menthol was similarly found to strongly reduce thermal 
hyperalgesia and mechanical allodynia but increase withdrawal responses from a 4 oC cold 
plate 77. Mediator specificity was established by antisense knockdown in this study too. 
Interestingly the analgesic effects of TRPM8 agonists were not observed in an alternative 
neuropathic pain model (SNL, spinal nerve ligation) 87 where TRPA1 has been implicated 88. 
Evidence for TRPM8-mediated analgesia was also provided in the formalin-induced flinching 
model where cool-induced analgesia was attenuated in TRPM8-/- mice compared to controls 
44. Recent work provides robust support for the idea of TRPM8-mediated analgesia, showing 
that systemic or topical administration of menthol diminishes pain behaviour due to noxious 
heat, TRPV1 or TRPA1 activators or intraperitoneal acidification as well as attenuating 
inflammation-induced mechanical hypersensitivity 89. The critical role of TRPM8 was clearly 
demonstrated through abrogation of effects in the presence of a highly selective TRPM8 
antagonist or in TRPM8-/- mice. Powerful analgesic effects of systemic menthol against 
formalin-induced flinching and inflammatory hypersensitivity have also been recently 
described at rather higher dosage levels, although in this case TRPM8-independent 
mechanisms may also contribute significantly 90. Key supportive data have also been 
provided through experiments on targeted ablation of TRPM8-expressing neurons where the 
cooling-evoked attenuation of mechanical allodynia seen in the CCI neuropathic pain model 
in control animals was abrogated by toxin-evoked TRPM8 ablation 60. Corresponding results 
were seen in TRPM8-/- mice.  Further evidence shows that pain state-induced synaptic 
hypersensitivity not only at the spinal cord but also forebrain levels can be reversed by 
topical administration of TRPM8 agonist; with the involvement of TRPM8 established 
through blockade by a highly selective antagonist 91. Taken together, these observations 
firmly establish that TRPM8 activation is able to gate-out hypersensitive nociceptive inputs 
and activation of the CNS in chronic pain statess, most likely through the spinal influence of 
the TRPM8-expressing subset of sensory afferents. 
So a case can be made for the use of either antagonists or agonists at TRPM8 in the treatment 
of pain. Antagonists may be useful to treat the cool allodynia associated with chronic pain 
states. Effects are likely to be limited to this modality however, as they would influence only 
the sensory detection of cool that involves TRPM8 and not the central sensitisation that leads 
to parallel problems of mechanical allodynia and thermal hyperalgesia. Antagonists could 
potentially be considered for treating acute cold pain in naive subjects but any evidence to 
validate this is much less strong than that illustrating the role of TRPM8 in innocuous cool 
thermosensation. It may well be that other factors play a key part in noxious cold sensing so 
any effect of TRPM8 blockade may be less robust; this will become clear in future work. 
Agonists show great promise in that they are now well documented to produce efficacious 
analgesia in hypersensitive pain states where there appear to inhibit central sensitisation and 
therefore reverse chronic pain of a number of different modalities. Both neuropathic and 
inflammatory pain hypersensitivity can be effectively targeted. One caveat with this approach 
would be that cool allodynia may be exacerbated, although it would be predicted that the 
analgesic effects of TRPM8 agonists suppressing central hypersensitivity act in opposition to 
any enhancement of peripheral cool sensing and thereby ameliorate any cool allodynia. 
Clinical evidence in chronic pain patients supports this idea, as cool allodynia does not seem 
to be a problematic issue 81,	  92,	  93. Care is also needed in evaluation of the therapeutic window 
because of the possibility of noxious sensations if supra-therapeutic concentrations of 
agonists are reached. Either strategy (as with any analgesic intervention) could potentially 
encounter on-target side effects in other tissues or off-target effects due to insufficient 
pharmacological specificity; a medicinal chemistry issue around the particular 
pharmacophore utilised. As TRPM8 is expressed in relatively few tissues, the on-target side-
effect issue may be relatively unproblematic, especially if agents are applied topically to 
dermatomes around the site of chronic pain to access selectively the relevant TRPM8 
afferents and limit the systemic drug load. For both antagonists and agonists a further 
possible issue that would need to be evaluated might be disruption of central 
thermoregulation, as identified in the case of TRPV1 antagonists.  
TRPM8 in thermoregulation: 
When antagonists of the noxious-heat sensing channel TRPV1 were tested in vivo as 
potential analgesics, significant effects on regulation of core body temperature became 
apparent. TRPV1 antagonists caused hyperthermia, thermogenesis and vasoconstriction in 
wild type but not TRPV1-/- mice 94,	  95. Although in contrast to TRPV1, TRPM8 is absent from 
central thermoregulatory centres in the hypothalamus, potential effects of TRPM8 agonists or 
antagonists on core temperature have been investigated.  Intraperitoneal injection of icilin at 
high concentrations produces a characteristic acute shivering behaviour known as “Wet Dog 
Shakes”, presumably by stimulating visceral afferents, and this response is attenuated in   
TRPM8-/- mice 45,	  96,	  97. Systemic or topical administration of menthol or icilin (at relatively 
high doses) leads to a transient increase in core temperature, presumably an attempt at 
compensatory thermoregulation 98-­‐103. Accordingly systemic TRPM8 antagonists produce a 
transient reduction in core temperature 61,	   80,	   103,	   104. In both cases, some studies confirmed 
lack of effects in TRPM8-/- mice. Whether any significant thermoregulatory changes are 
observed at the doses therapeutically relevant for the treatment of chronic pain remains to be 
established.  
Pharmacology of TRPM8 antagonists and agonists:  
TRPM8 antagonists: 
For a number of years no highly selective antagonists of TRPM8 were available to help 
validate the inferred role of the channel in thermosensation and modulation of pain 
processing. Early studies identified that some TRPV1 antagonists also had affinity for 
TRPM8, providing the first useful but fairly non-selective tools. Capsazepine, BCTC and SB-
452533 were shown to be effective TRPM8 antagonists but with clearly lower potency than 
at TRPV1, posing difficulties for data interpretation in complex in vivo situations 105,	  106. The 
antifungal agent clotrimazole was identified as a relatively potent TRPM8 antagonist 107, but 
it additionally blocks K+ channels and activates both TRPV1 and TRPA1. Tryptamine 
derivatives such as 5-benzoyloxytryptamine were also unexpectedly shown to antagonise 
TRPM8 but may well impact on 5-HT receptor function and any potential effects on other 
pain-relevant channels are unknown 108. The first clearly selective TRPM8 agonist widely 
disclosed was AMTB, developed by Bayer 109, although its affinity was still only moderate. 
Other pharma; Glenmark, Amgen, Janssen, Johnson and Johnson have now developed a 
number of highly potent and selective TRPM8 antagonists with diverse chemical structures. 
These include benzothiophene sulphonamides and phosphonates, fused oxazoles and 
thiazoles, benzimidazoles, fused piperidines, aryl glycines, menthylamines and 
ylidenephthalides (although the last two may have some TRPA1/TRPV1 activity) 110-­‐118. 
Additional potent and effective TRPM8 antagonists from further structural series have been 
produced by Pfizer and Takeda 61,	  80 and even endogenous and plant cannabinoids inhibit at 
submicromolar concentrations 119; yielding a truly diverse array of pharmacophores as 
TRPM8 blockers (Figure 1).    
TRPM8 agonists: 
The prototypical TRPM8 agonist menthol (more precisely (-) menthol or IR, 2S, 5R-2-
isopropyl-5-methylcyclohexanol) is an effective but not particularly selective TRPM8 
agonist. In our studies measuring Ca2+ fluorescence responses of HEK-293 cells stably 
expressing human TRPM8 it shows a mean EC50 of 11.2 µM with efficacy 66% that of the 
benchmark agonist icilin, but a mean EC50 of 29.6 µM and 95% efficacy compared to allyl 
isothiocyanate (mustard oil) at TRPA1. The stereoisomers show an unremarkable structure-
activity relationship 13,	   36, but an extensive range of analogues has been produced, notably 
WS-12 and D-3263, which show greatly increased potency at TRPM8 120-­‐125.  The 
tetrahydropyrimidine-2-one, icilin, was reported to produce marked sensations of cold 126 and 
is established as a potent TRPM8 agonist with an EC50 of 0.3 µM and considerable selectivity 
against TRPA1 (about 300 fold in our assays), and even more against TRPV1 2,	  105. However 
icilin has substantial affinity as an antagonist at TRPV3  127. Thienopyrimidine compounds 
124 display moderate potency and selectivity, with a hydroxyethyl-substituted example 
showing an EC50 of 10 µM at TRPM8 and at least 20-fold selectivity over TRPA1 and 
TRPV1 in our hands. Perhaps the most enigmatic of TRPM8 agonists is an aliphatic 
phosphonate, WS-148, (1-(di-sec-butyl-phosphinoyl)-heptane), which is reported to show an 
EC50 of 4.1 µM at TRPM8, although its off-target profile has not been described 121. A recent 
report describes a series of isoxazole compounds as potent partial agonists in causing Ca2+ 
elevation in a DRG/neuroblastoma cell line that responds to menthol and expresses TRPM8 
mRNA 128. Further characterisation of these compounds will be interesting, especially as 
modelling of interactions with a quaternary structural model of the TRPM8 channel 129 
indicates a potential for both menthol-like and icilin-like interactions in the series 128 (Figure 
2). The development of new highly selective TRPM8 agonists as tools will be an important 
step forward as the majority of physiological studies carried out to date with TRPM8 agonists 
have utilised either menthol or icilin and unless additional strategies are incorporated to 
validate TRPM8 mediation some caution is needed in interpretation.   
Menthol can exert a wide range of TRPM8-independent effects, generally at somewhat 
higher concentrations than those that adequately activate TRPM8. These include potentiation 
of GABA and glycine currents, inhibition of α4β2- and α7-nicotinic cholinergic receptors, 
inhibition of 5-HT3 receptors, inhibition of Ca2+ and Na+ channels and local anaesthetic-like 
suppression of action potential firing and even at very high concentrations, desensitisation of 
TRPV3 and cell cycle arrest in proliferating cells 90,	   130-­‐143. Systemic menthol at low doses 
produces analgesia that principally involves TRPM8 89 while effects at considerably higher 
doses appear to involve disruption of Ca2+ and Na+ channels 90.   
Apart from its significant affinity for TRPV3, icilin has a number of additional effects. 
Inhibition of L-type Ca2+ channels is reported at similar sub-micromolar concentrations 
similar to those causing activation of TRPM8 but the basis is rather unclear as the effect 
increased slowly, without saturating, over 5 orders of magnitude of concentration 87. Icilin at 
somewhat higher concentrations is also reported to activate epithelial Na+ channels, evoke a 
distinct inhibitory effect on TRPM8 gating that is separate from Ca2+-dependent channel 
desensitisation and even lead to cell cycle arrest in proliferating cells 15,	  144-­‐146.      
Modulation of TRPM8 function by cellular signalling: 
Lipids: 
Like other TRP channels, TRPM8 is prominently modulated by PIP2, which slows channel 
rundown in isolated membrane patches and acts to facilitate channel activation by cooling or 
chemical agents 147-­‐149. Mutation of TRP box PIP2-binding residues greatly reduces TRPM8 
responses to stimuli including chemical agonists 91,	  148.  Enzymatic activity of phospholipase 
C (PLC), including that evoked by agonist stimulation of PLC-coupled receptors, can lead to 
dynamic local depletion of PIP2 concentrations and suppression of TRPM8 function 147,	   148,	  
150,	  151. A PIP2 binding protein, PIRT, is widely expressed in DRG cells and enhances menthol 
responses in HEK-293 cells co-transfected with TRPM8, while PIRT-/- mice show partially 
attenuated avoidance of cool and cold surfaces 152. 
Lysophospholipids and polyunsaturated fatty acids, products of phospholipase A2 (PLA2) 
action on membrane phospholipids, reciprocally enhance or inhibit TRPM8 function 
respectively 153-­‐155.   Inhibition of PLA2 enzyme activity attenuated the hypersensitivity to 10 
oC cold induced by the intraplantar injection of icilin at a high concentration, but not due to 
menthol 63.  Corresponding experiments in mutant mice indicated the involvement of TRPM8 
in hypersensitivity due to intraplantar icilin but TRPA1 in that induced by menthol.  PLA2 
activation downstream of receptor activation and kinase cascades could therefore lead to 
complex profiles of TRPM8 modulation. Changes in membrane lipid composition may also 
influence the localisation of TRPM8 within cholesterol-rich lipid rafts, which appears to 
normally down-regulate its responsiveness to stimuli 156.  Volatile general anaesthetics have 
been reported to affect TRPM8 with a transient enhancement followed by a sustained 
inhibition of function, effects that may reflect alterations in the membrane protein:lipid 
interface 157. 
Kinases: 
The intracellular domains of TRPM8 contain a number of potential regulatory 
phosphorylation sites that match more or less closely to the consensus target sequences of 
several common kinases 158. Phorbol ester or receptor-mediated activation of protein kinase C 
(PKC) inhibits TRPM8 function 159-­‐162 but there is little firm evidence that direct 
phosphorylation is responsible, rather a downstream calcineurin-dependent 
dephosphorylation mechanism 159.  Protein kinase A (PKA) activation brought about by 
forskolin or 8-Br-cAMP is reported to reduce chemical agonist-evoked TRPM8 responses or 
DRG neuronal responses to cooling 119,	   161, although in our experiments with TRPM8-
expressing HEK-293 cells we observe significant inhibitory effects of phorbol 12,13-
dibutyrate but not forskolin.  A similar lack of effect of forskolin or 8-Br-cAMP was reported 
in cultured DRG cells 162 and another study even indicated that basal function of TRPM8 was 
dependent on patent phosphorylation by PKA 163.  
TRPM8-positive sensory neurons are thought to be dependent on the tyrosine kinase receptor 
for Nerve Growth Factor, TrkA during development and during cell culture 164,	  165 so tyrosine 
phosphorylation-dependent signalling cascades might modulate TRPM8.  Although TrkA 
appears not to be generally co-expressed with TRPM8 in adult sensory neurons 165, around 
half of the TRPM8-positive TG and DRG cells express the GFRα3 receptor for another 
neuronal growth factor, artemin, and a subset of these also contain TrkA 166. Intraplantar 
injection of artemin enhanced behavioural responses to evaporative cooling with acetone, a 
response that was absent in TRPM8-/- mice, but also reduced withdrawal latencies to noxious 
heat 166. Intraplantar NGF had a similar but less marked effect on cooling responses. The 
intracellular signalling cascades underlying these modulatory effects remain to be elucidated.     
G protein-coupled receptor signalling: 
Intracellular signalling from the mainly Gi/Go-coupled α2A-adrenoreceptor (most likely the 
inhibition of adenylyl cyclases) has been reported to inhibit TRPM8 function both in a 
heterologous cell expression system and in a small subpopulation of menthol-sensitive 
sensory neurons 163, with reducing phosphorylation status of PKA target sites thought to be 
responsible. The mainly Gq/G11-coupled M3 muscarinic receptor also inhibits TRPM8 in co-
transfected HEK-293 cells 155. Rather than through anticipated candidate mechanisms such as 
PLC-dependent PIP2 depletion, this appears to involve PLA2-dependent arachidonic acid 
production through a process unaffected by a selective PLC inhibitor.  In addition the mainly 
Gq/G11-coupled B2 bradykinin receptor can reduce TRPM8 channel currents and Ca2+ 
elevation in co-transfected cells and in a subpopulation of DRG cells, through a process not 
significantly affected by inhibitors of PLC or PKC 167.  The direct activator of PKC phorbol 
12-myristate, 13-acetate had no apparent effect on TRPM8 activity in these experiments, in 
contrast to earlier reports 159-­‐162.  Evidence was provided in support of a PLC-independent 
mechanism of Gq binding to the channel to cause its inhibition, centring on effects of a 
chimeric Gαq/Gαi construct to avoid PLC activation as wild-type, constitutively active and a 
previously described PLC-disabled mutant Gαq were able to trigger the earlier proposed 
inhibitory mechanism of PIP2 depletion.  Wild type and constitutively active Gαq were 
reported to be associated with TRPM8 in chelation-affinity and immunoprecipitation 
experiments; controls were provided using cells transfected with a single construct alone.  In 
addition Gαq from cell lysates was captured by GST fusion constructs of both N- and C-
terminal domains of TRPM8.  An additional protein that may be of relevance to these 
findings is G protein-coupled receptor kinase 2 (GRK2), which is recruited to the vicinity of 
activated receptors and is known to sequester Gαq 168. Interestingly the region of Gαq 
replaced in the Gαq/Gαi chimera is important for GRK2- as well as PLC-β-interaction 169.  
GRK2 could potentially be associated with the B2 receptor in transfected cells or in vivo and 
affect Gαq localisation and availability. An activated construct of the Gαq congener Gα11, is 
reported to have a lesser effect on TRPM8 compared to Gαq 170 and the same pattern is seen 
in the impairment of inositol phosphate signalling caused by GRK2 binding to the two G 
proteins 171. Whether or not GRK2 plays any part in Gαq : TRPM8 interactions is yet to be 
explored. Surprisingly though, the intraplantar injection of bradykinin (at doses effective in 
causing heat hypersensitivity, 172 had no effect at all on behavioural responses to evaporative 
cooling in mice 166.  Additional data consistent with Gαq inhibition of TRPM8 was provided 
in experiments investigating the pruritogenic receptor MrgprA3 in a small minority of DRG 
neurons that respond to capsaicin, allyl isothiocyanate and menthol 173. MrgprA3 activation 
partially reduced subsequent menthol responses in around half of these cells, whereas 
capsaicin responses were enhanced through a distinct mechanism 173. The difficulties in 
distilling a simple unified model of TRPM8 channel regulation are emphasised by data 
indicating a completely contrasting process; the activation of Gαq and PLC by TRPM8 itself 
174. This report describes menthol-evoked Ca2+ mobilisation from intracellular stores through 
a TRPM8-dependent process involving PLC activation, although menthol at high 
concentrations is also known to exert TRPM8-independent effects on endoplasmic reticulum 
175. Correspondingly, fluorescence resonance energy transfer (FRET) measurements indicated 
close proximity between fluorophore-tagged TRPM8 and Gαq that was considered to underlie 
G protein and PLC activation. The overall picture remains to be clarified, although 
potentially multiple processes could operate concurrently. 
A recent report describes a novel mechanism for the upregulation of TRPM8 function, which 
centres on a newly discovered molecular signalling complex between the 5-HT1B receptor 
and TRPM8 91 (Figure 3).  The channel associates directly with the 5-HT1B receptor but not 
with other G protein-coupled receptors, in HEK-293 cells and in small DRG neurons. 5-HT1B 
receptor activation amplifies TRPM8 responses to icilin or menthol through a mechanism 
dependent on phospholipase D1 (PLD1), which is also incorporated into the signalling 
complex. Evidence was provided that the process by which PLD can enhance channel 
function involves a stimulatory effect on phosphatidylinositol 4-phosphate (PIP) 5-kinase, 
leading to elevated levels of PIP2, the allosteric enhancer of TRPM8.   In chronic pain models 
the combined treatment with 5-HT1B agonist and TRPM8 agonist was shown to amplify icilin 
(or menthol) -induced reversal of synaptic hypersensitivity in the CNS and enhance TRPM8 
analgesia.     
CNS processes activated by TRPM8-positive afferents: 
In the superficial dorsal horn of the spinal cord there are various categories of supraspinally 
projecting neurons including polymodal nociceptors and non-nociceptive cool receptors, 
indicating at least partially distinct spinal processing and onward transmission of innocuous 
cool sensation 176-­‐179. TRPM8-expressing afferents, visualised in mice with TRPM8 
promoter-targeted GFP constructs, terminate in outer laminae II and laminae I of spinal 
dorsal horn 33,	  34. These terminals overlap with the zone of peptidergic nociceptor termination 
as exemplified by CGRP and substance P immunofluorescence (but show minimal co-
staining at the single fibre level), while essentially avoiding the region of IB4-reactive non-
peptidergic nociceptor termination in inner laminae II. Cadherin-8 is expressed in laminae I, 
IIouter and especially IIinner of the dorsal horn and is also present in a subset of small DRG 
cells, many of which co-express TRPM8 180. Ultrastructural analysis indicated both pre- and 
post-synaptic cadherin-8 expression within complex glomerular synapses. Recording from 
dorsal horn neurons in slices of wild-type mice, menthol-evoked increased mEPSP frequency 
and this effect was abolished in cadherin-8-/- animals, indicating that cadherin-8 may be 
required for functional connectivity between TRPM8 afferents and target neurons in 
superficial dorsal horn 180.  A further ultrastructural study showed that TRPM8-positive C- 
and Aδ-fibre terminals entered into synaptic connections that were generally simple dendritic, 
less commonly complex glomerular and occasionally axo-axonic in nature 181. In the 
trigeminal sensory nuclei there was evidence for a segregated localisation of TRPM8 
afferents that were positive for CGRP and those that expressed TRPM8 alone. 
 In a transgenic mouse line that expresses GFP in a subset of GABAergic laminae II 
interneurons, tonic central cells 182, menthol or icilin increase mEPSP frequency in these 
neurons, consistent with a direct input from TRPM8 positive afferents and a role in cool 
sensing 183. Interneuron cross-connections 184,	   185 could then lead to inhibitory effects on 
vertical and transient central excitatory interneurons involved in processing Aδ- and C-fibre 
nociceptive inputs 183.  Such pathways could contribute to the gating-out of hypersensitive 
responses to nociceptive inputs and reversal of pain behaviour seen when icilin or menthol 
are administered at low doses in chronic pain models 36,	   91.  In those studies any major 
contribution of opioid receptors at the spinal level was excluded but a key mediating role of 
Group II and Group III metabotropic glutamate receptors was identified, each known to be 
expressed at both pre- and post-synaptic locations. There is evidence however to support an 
involvement of κ-opioid receptors in the acute analgesic effects of systemic menthol but the 
site of action is likely to be an unknown supraspinal location as effects were attenuated when 
κ-opioid antagonist was delivered intracerebroventricularly 85. A further study reported that 
acute analgesic effects of the menthol congener WS-12 (at a rather high intraperitoneal dose) 
in the hot plate test were diminished by a systemic naloxone, a general opioid receptor 
antagonist 89. These reports could both be consistent with a supraspinal role of κ-opioid 
receptors in TRPM8 ligand-induced analgesia but in neither case was it shown explicitly that 
effects were TRPM8-mediated. Mice in which the developmental transcription factor Bhlhb5 
is constitutively deleted lack a further subpopulation of inhibitory GABAergic interneurons 
in superficial dorsal horn and display pathological itch 186.  When these neurons were 
genetically tagged they were shown to co-express either galanin/dynorphin or neuronal nitric 
oxide synthase and be activated by capsaicin, allyl isothiocyanate and menthol each of which 
is reported to exert antipruritic influences 187.  Thus these cells may receive input from 
TRPM8 afferents and may influence itch through dynorphin/κ-opioid receptor mechanisms, 
although preprodynorphin-/- mice do not replicate the phenotype 187. Importantly though, 
Bhlhb5-/- mice do not exhibit any pain phenotype 186, so perhaps are dissociated from 
pathways underpinning TRPM8 analgesia. A further recent study reported that in isolated 
DRG neurons, the µ-opioid receptor agonist morphine, at a relatively high concentration, 
causes a small (15 %) attenuation of menthol-induced currents and disruption of menthol-
induced Ca2+ entry 188.  Data were provided to suggest that µ-opioid receptor 
immunoreactivity was found in TRPM8 immunoprecipitates from HEK-293 cells transfected 
with TRPM8 plus µ-opioid receptor but not cells transfected with TRPM8 alone and also that 
morphine may promote TRPM8 internalisation. Evidence that µ-opioid receptors are 
expressed in native TRPM8-positive afferents is yet to be provided by immunofluorescence 
or equivalent approaches. Morphine-evoked analgesia was tested on cold responses of 
TRPM8-/- mice and found to be less marked than in the wild type, but the marked re-setting 
of pain thresholds in the mutant mouse line means that it is hard to interpret the comparison 
with certainty. The robust antinociceptive effects of µ-opioid receptors that are known to be 
exerted at spinal dorsal horn and brainstem levels would need to be taken into account for a 
holistic analysis. 
A further report relating to the idea of functional interaction between different groups of 
afferent inputs describes the effects of toxin ablation of CGRP-expressing nociceptive 
afferents 189. Interestingly, their removal amplifies behavioural responses to an evaporative 
cooling stimulus provided by acetone and reduces withdrawal latency from a cold plate at 
noxious temperatures. This is consistent with the general concept of crossover gating between 
different classes of afferent pathways, and indicates that concurrent activation of analgesic 
inputs associated with innocuous cool sensation and blockade of nociceptive inputs may 
bring about a synergistic, greater than additive, therapeutic outcome.   
Conclusions: 
Over the small number of years since its discovery, the TRPM8 ion channel has become 
established as a promising target for analgesic intervention. Abundant evidence indicates that 
TRPM8 is key to the sensing of innocuous cool temperatures and is expressed in a 
subpopulation of small DRG/TG neurons, which course to the superficial dorsal horn in 
parallel to nociceptive afferents. In chronic pain states, the central sensitisation that underpins 
hypersensitive pain behaviour is attenuated by this TRPM8-positive input, acting to gate-out 
nociceptive processing and produce an analgesic effect. TRPM8 agonists can usefully target 
this mechanism to provide efficacious analgesia in chronic neuropathic or inflammatory pain. 
TRPM8 agonists are thought to exert mixed effects on one particular sign of chronic pain, 
that is cool allodynia, where they may both amplify innocuous cool sensing and attenuate 
central sensitisation; the overall outcome therefore being to ameliorate any allodynia. TRPM8 
antagonists are being investigated for the treatment of cool allodynia; while they are likely to 
be effective in reducing the cool sensing input itself, there is no basis to expect any effect on 
central sensitisation or any impact on other modalities of chronic hypersensitive pain. Any 
participation of TRPM8 in noxious cold sensing in naive subjects is less clearly documented 
at present, with only a minority of TRPM8-positive DRG/TG cells expressing nociceptive 
markers, so any potential for intervention there remains to be validated. In the future the 
development of new highly selective chemical ligands for TRPM8 will be crucial, not only in 
providing tools to help unravel the complex neurobiology underlying its impact on pain 




1. Tsavaler L, Shapero MH, Morkowski S, Laus R. Trp-p8, a novel prostate-specific 
gene, is up-regulated in prostate cancer and other malignancies and shares high homology 
with transient receptor potential calcium channel proteins. Cancer Res 2001; 61(9): 3760-9. 
2. McKemy DD, Neuhausser WM, Julius D. Identification of a cold receptor reveals a 
general role for TRP channels in thermosensation. Nature 2002; 416(6876): 52-8. 
3. Peier AM, Moqrich A, Hergarden AC, et al. A TRP channel that senses cold stimuli 
and menthol. Cell 2002; 108(5): 705-15. 
4. Erler I, Al-Ansary DM, Wissenbach U, Wagner TF, Flockerzi V, Niemeyer BA. 
Trafficking and assembly of the cold-sensitive TRPM8 channel. The Journal of Biological 
Chemistry 2006; 281(50): 38396-404. 
5. Tsuruda PR, Julius D, Minor DL, Jr. Coiled coils direct assembly of a cold-activated 
TRP channel. Neuron 2006; 51(2): 201-12. 
6. Phelps CB, Gaudet R. The role of the N terminus and transmembrane domain of 
TRPM8 in channel localization and tetramerization. The Journal of Biological Chemistry 
2007; 282(50): 36474-80. 
7. Bandell M, Story GM, Hwang SW, et al. Noxious cold ion channel TRPA1 is 
activated by pungent compounds and bradykinin. Neuron 2004; 41(6): 849-57. 
8. Brauchi S, Orta G, Salazar M, Rosenmann E, Latorre R. A hot-sensing cold receptor: 
C-terminal domain determines thermosensation in transient receptor potential channels. The 
Journal of Neuroscience 2006; 26(18): 4835-40. 
9. Brauchi S, Orta G, Mascayano C, et al. Dissection of the components for PIP2 
activation and thermosensation in TRP channels. Proceedings of the National Academy of 
Sciences of the United States of America 2007; 104(24): 10246-51. 
10. Pertusa MI, Gonz Aacutelez A, Hardy P, Madrid R, Viana FE. Bidirectional 
Modulation of Thermal and Chemical Sensitivity of TRPM8 Channels by the Initial Region 
of the N-Terminal Domain. The Journal of Biological Chemistry 2014. 
11. Andersson DA, Chase HW, Bevan S. TRPM8 activation by menthol, icilin, and cold 
is differentially modulated by intracellular pH. The Journal of Neuroscience 2004; 24(23): 
5364-9. 
12. Chuang HH, Neuhausser WM, Julius D. The super-cooling agent icilin reveals a 
mechanism of coincidence detection by a temperature-sensitive TRP channel. Neuron 2004; 
43(6): 859-69. 
13. Bandell M, Dubin AE, Petrus MJ, et al. High-throughput random mutagenesis screen 
reveals TRPM8 residues specifically required for activation by menthol. Nature 
Neuroscience 2006; 9(4): 493-500. 
14. Voets T, Owsianik G, Janssens A, Talavera K, Nilius B. TRPM8 voltage sensor 
mutants reveal a mechanism for integrating thermal and chemical stimuli. Nature Chemical 
Biology 2007; 3(3): 174-82. 
15. Kuhn FJ, Kuhn C, Luckhoff A. Inhibition of TRPM8 by icilin distinct from 
desensitization induced by menthol and menthol derivatives. The Journal of Biological 
Chemistry 2009; 284(7): 4102-11. 
16. Brauchi S, Orio P, Latorre R. Clues to understanding cold sensation: thermodynamics 
and electrophysiological analysis of the cold receptor TRPM8. Proceedings of the National 
Academy of Sciences of the United States of America 2004; 101(43): 15494-9. 
17. Voets T, Droogmans G, Wissenbach U, Janssens A, Flockerzi V, Nilius B. The 
principle of temperature-dependent gating in cold- and heat-sensitive TRP channels. Nature 
2004; 430(7001): 748-54. 
18. Hui K, Guo Y, Feng ZP. Biophysical properties of menthol-activated cold receptor 
TRPM8 channels. Biochemical and Biophysical Research Communications 2005; 333(2): 
374-82. 
19. Matta JA, Ahern GP. Voltage is a partial activator of rat thermosensitive TRP 
channels. The Journal of Physiology 2007; 585(Pt 2): 469-82. 
20. Hayashi T, Kondo T, Ishimatsu M, et al. Expression of the TRPM8-immunoreactivity 
in dorsal root ganglion neurons innervating the rat urinary bladder. Neurosci Res 2009; 65(3): 
245-51. 
21. Johnson CD, Melanaphy D, Purse A, Stokesberry SA, Dickson P, Zholos AV. 
Transient receptor potential melastatin 8 channel involvement in the regulation of vascular 
tone. American Journal of Physiology Heart and Circulatory Physiology 2009; 296(6): 
H1868-77. 
22. Materazzi S, Nassini R, Gatti R, Trevisani M, Geppetti P. Cough sensors. II. Transient 
receptor potential membrane receptors on cough sensors. Handbook of Experimental 
Pharmacology 2009; (187): 49-61. 
23. Babes A, Ciobanu AC, Neacsu C, Babes RM. TRPM8, a sensor for mild cooling in 
mammalian sensory nerve endings. Curr Pharm Biotechnol 2011; 12(1): 78-88. 
24. Harrington AM, Hughes PA, Martin CM, et al. A novel role for TRPM8 in visceral 
afferent function. Pain 2011; 152(7): 1459-68. 
25. Jun JH, Kang HJ, Jin MH, et al. Function of the Cold Receptor (TRPM8) Associated 
with Voiding Dysfunction in Bladder Outlet Obstruction in Rats. International Neurourology 
Journal 2012; 16(2): 69-76. 
26. Plevkova J, Kollarik M, Poliacek I, et al. The role of trigeminal nasal TRPM8-
expressing afferent neurons in the antitussive effects of menthol. Journal of Applied 
Physiology 2013; 115(2): 268-74. 
27. Ramachandran R, Hyun E, Zhao L, et al. TRPM8 activation attenuates inflammatory 
responses in mouse models of colitis. Proceedings of the National Academy of Sciences of the 
United States of America 2013; 110(18): 7476-81. 
28. Blackshaw LA. Transient receptor potential cation channels in visceral sensory 
pathways. British Journal of Pharmacology 2014; 171(10): 2528-36. 
29. Zhang L, Jones S, Brody K, Costa M, Brookes SJ. Thermosensitive transient receptor 
potential channels in vagal afferent neurons of the mouse. American Journal of Physiology 
Gastrointestinal and Liver Physiology 2004; 286(6): G983-91. 
30. Hondoh A, Ishida Y, Ugawa S, et al. Distinct expression of cold receptors (TRPM8 
and TRPA1) in the rat nodose-petrosal ganglion complex. Brain Research 2010; 1319: 60-9. 
31. Zhao H, Sprunger LK, Simasko SM. Expression of transient receptor potential 
channels and two-pore potassium channels in subtypes of vagal afferent neurons in rat. 
American Journal of Physiology Gastrointestinal and Liver Physiology 2010; 298(2): G212-
21. 
32. Du J, Yang X, Zhang L, Zeng YM. Expression of TRPM8 in the distal cerebrospinal 
fluid-contacting neurons in the brain mesencephalon of rats. Cerebrospinal Fluid Research 
2009; 6: 3. 
33. Takashima Y, Daniels RL, Knowlton W, Teng J, Liman ER, McKemy DD. Diversity 
in the neural circuitry of cold sensing revealed by genetic axonal labeling of transient 
receptor potential melastatin 8 neurons. The Journal of Neuroscience 2007; 27(51): 14147-
57. 
34. Dhaka A, Earley TJ, Watson J, Patapoutian A. Visualizing cold spots: TRPM8-
expressing sensory neurons and their projections. The Journal of Neuroscience 2008; 28(3): 
566-75. 
35. Nealen ML, Gold MS, Thut PD, Caterina MJ. TRPM8 mRNA is expressed in a subset 
of cold-responsive trigeminal neurons from rat. Journal of Neurophysiology 2003; 90(1): 
515-20. 
36. Proudfoot CJ, Garry EM, Cottrell DF, et al. Analgesia mediated by the TRPM8 cold 
receptor in chronic neuropathic pain. Curr Biol 2006; 16(16): 1591-605. 
37. Kobayashi K, Fukuoka T, Obata K, et al. Distinct expression of TRPM8, TRPA1, and 
TRPV1 mRNAs in rat primary afferent neurons with adelta/c-fibers and colocalization with 
trk receptors. The Journal of Comparative Neurology 2005; 493(4): 596-606. 
38. Okazawa M, Inoue W, Hori A, Hosokawa H, Matsumura K, Kobayashi S. Noxious 
heat receptors present in cold-sensory cells in rats. Neuroscience Letters 2004; 359(1-2): 33-
6. 
39. Pogorzala LA, Mishra SK, Hoon MA. The cellular code for mammalian 
thermosensation. The Journal of Neuroscience 2013; 33(13): 5533-41. 
40. Hwang SJ, Oh JM, Valtschanoff JG. The majority of bladder sensory afferents to the 
rat lumbosacral spinal cord are both IB4- and CGRP-positive. Brain Research 2005; 1062(1-
2): 86-91. 
41. Karashima Y, Talavera K, Everaerts W, et al. TRPA1 acts as a cold sensor in vitro 
and in vivo. Proceedings of the National Academy of Sciences of the United States of 
America 2009; 106(4): 1273-8. 
42. Bautista DM, Siemens J, Glazer JM, et al. The menthol receptor TRPM8 is the 
principal detector of environmental cold. Nature 2007; 448(7150): 204-8. 
43. Colburn RW, Lubin ML, Stone DJ, Jr., et al. Attenuated cold sensitivity in TRPM8 
null mice. Neuron 2007; 54(3): 379-86. 
44. Dhaka A, Murray AN, Mathur J, Earley TJ, Petrus MJ, Patapoutian A. TRPM8 is 
required for cold sensation in mice. Neuron 2007; 54(3): 371-8. 
45. Knowlton WM, Bifolck-Fisher A, Bautista DM, McKemy DD. TRPM8, but not 
TRPA1, is required for neural and behavioral responses to acute noxious cold temperatures 
and cold-mimetics in vivo. Pain 2010; 150(2): 340-50. 
46. Reid G, Flonta ML. Ion channels activated by cold and menthol in cultured rat dorsal 
root ganglion neurones. Neuroscience Letters 2002; 324(2): 164-8. 
47. de la Pena E, Malkia A, Cabedo H, Belmonte C, Viana F. The contribution of TRPM8 
channels to cold sensing in mammalian neurones. The Journal of Physiology 2005; 567(Pt 2): 
415-26. 
48. Xing H, Ling J, Chen M, Gu JG. Chemical and cold sensitivity of two distinct 
populations of TRPM8-expressing somatosensory neurons. Journal of Neurophysiology 
2006; 95(2): 1221-30. 
49. Teichert RW, Raghuraman S, Memon T, et al. Characterization of two neuronal 
subclasses through constellation pharmacology. Proceedings of the National Academy of 
Sciences of the United States of America 2012; 109(31): 12758-63. 
50. Karashima Y, Damann N, Prenen J, et al. Bimodal action of menthol on the transient 
receptor potential channel TRPA1. J Neurosci 2007; 27(37): 9874-84. 
51. Story GM, Peier AM, Reeve AJ, et al. ANKTM1, a TRP-like channel expressed in 
nociceptive neurons, is activated by cold temperatures. Cell 2003; 112(6): 819-29. 
52. Sarria I, Ling J, Xu GY, Gu JG. Sensory discrimination between innocuous and 
noxious cold by TRPM8-expressing DRG neurons of rats. Molecular Pain 2012; 8: 79. 
53. Amaya F, Oh-hashi K, Naruse Y, et al. Local inflammation increases vanilloid 
receptor 1 expression within distinct subgroups of DRG neurons. Brain Research 2003; 
963(1-2): 190-6. 
54. Teliban A, Bartsch F, Struck M, Baron R, Janig W. Responses of intact and injured 
sural nerve fibers to cooling and menthol. Journal of Neurophysiology 2014; 111(10): 2071-
83. 
55. Campero M, Baumann TK, Bostock H, Ochoa JL. Human cutaneous C fibres 
activated by cooling, heating and menthol. The Journal of Physiology 2009; 587(Pt 23): 
5633-52. 
56. Wasner G, Schattschneider J, Binder A, Baron R. Topical menthol--a human model 
for cold pain by activation and sensitization of C nociceptors. Brain 2004; 127(Pt 5): 1159-
71. 
57. Namer B, Seifert F, Handwerker HO, Maihofner C. TRPA1 and TRPM8 activation in 
humans: effects of cinnamaldehyde and menthol. Neuroreport 2005; 16(9): 955-9. 
58. Hatem S, Attal N, Willer JC, Bouhassira D. Psychophysical study of the effects of 
topical application of menthol in healthy volunteers. Pain 2006; 122(1-2): 190-6. 
59. Parra A, Madrid R, Echevarria D, et al. Ocular surface wetness is regulated by 
TRPM8-dependent cold thermoreceptors of the cornea. Nature Medicine 2010; 16(12): 1396-
9. 
60. Knowlton WM, Palkar R, Lippoldt EK, et al. A Sensory-Labeled Line for Cold: 
TRPM8-Expressing Sensory Neurons Define the Cellular Basis for Cold, Cold Pain, and 
Cooling-Mediated Analgesia. The Journal of Neuroscience 2013; 33(7): 2837-48. 
61. Knowlton WM, Daniels RL, Palkar R, McCoy DD, McKemy DD. Pharmacological 
blockade of TRPM8 ion channels alters cold and cold pain responses in mice. PLoS One 
2011; 6(9): e25894. 
62. Morin C, Bushnell MC. Temporal and qualitative properties of cold pain and heat 
pain: a psychophysical study. Pain 1998; 74(1): 67-73. 
63. Gentry C, Stoakley N, Andersson DA, Bevan S. The roles of iPLA2, TRPM8 and 
TRPA1 in chemically induced cold hypersensitivity. Molecular Pain 2010; 6: 4. 
64. Braz JM, Basbaum AI. Differential ATF3 expression in dorsal root ganglion neurons 
reveals the profile of primary afferents engaged by diverse noxious chemical stimuli. Pain 
2010; 150(2): 290-301. 
65. Ross SE. Pain and itch: insights into the neural circuits of aversive somatosensation in 
health and disease. Current Opinion in Neurobiology 2011; 21(6): 880-7. 
66. Vetter I, Hein A, Sattler S, et al. Amplified cold transduction in native nociceptors by 
M-channel inhibition. J Neurosci 2013; 33(42): 16627-41. 
67. del Camino D, Murphy S, Heiry M, et al. TRPA1 contributes to cold hypersensitivity. 
J Neurosci 2010; 30(45): 15165-74. 
68. Madrid R, de la Pena E, Donovan-Rodriguez T, Belmonte C, Viana F. Variable 
threshold of trigeminal cold-thermosensitive neurons is determined by a balance between 
TRPM8 and Kv1 potassium channels. J Neurosci 2009; 29(10): 3120-31. 
69. Yamamoto Y, Hatakeyama T, Taniguchi K. Immunohistochemical colocalization of 
TREK-1, TREK-2 and TRAAK with TRP channels in the trigeminal ganglion cells. 
Neuroscience Letters 2009; 454(2): 129-33. 
70. Sarria I, Ling J, Gu JG. Thermal sensitivity of voltage-gated Na+ channels and A-type 
K+ channels contributes to somatosensory neuron excitability at cooling temperatures. 
Journal of Neurochemistry 2012; 122(6): 1145-54. 
71. Zimmermann K, Leffler A, Babes A, et al. Sensory neuron sodium channel Nav1.8 is 
essential for pain at low temperatures. Nature 2007; 447(7146): 855-8. 
72. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity 
by central neural plasticity. The Journal of Pain 2009; 10(9): 895-926. 
73. Obata K, Katsura H, Mizushima T, et al. TRPA1 induced in sensory neurons 
contributes to cold hyperalgesia after inflammation and nerve injury. The Journal of Clinical 
Investigation 2005; 115(9): 2393-401. 
74. Ji G, Zhou S, Carlton SM. Intact Adelta-fibers up-regulate transient receptor potential 
A1 and contribute to cold hypersensitivity in neuropathic rats. Neuroscience 2008; 154(3): 
1054-66. 
75. Frederick J, Buck ME, Matson DJ, Cortright DN. Increased TRPA1, TRPM8, and 
TRPV2 expression in dorsal root ganglia by nerve injury. Biochemical and Biophysical 
Research Communications 2007; 358(4): 1058-64. 
76. Xing H, Chen M, Ling J, Tan W, Gu JG. TRPM8 mechanism of cold allodynia after 
chronic nerve injury. J Neurosci 2007; 27(50): 13680-90. 
77. Su L, Wang C, Yu YH, Ren YY, Xie KL, Wang GL. Role of TRPM8 in dorsal root 
ganglion in nerve injury-induced chronic pain. BMC Neurosci 2011; 12: 120. 
78. Caspani O, Zurborg S, Labuz D, Heppenstall PA. The contribution of TRPM8 and 
TRPA1 channels to cold allodynia and neuropathic pain. PLoS One 2009; 4(10): e7383. 
79. Staaf S, Oerther S, Lucas G, Mattsson JP, Ernfors P. Differential regulation of TRP 
channels in a rat model of neuropathic pain. Pain 2009; 144(1-2): 187-99. 
80. Patel R, Goncalves L, Newman R, et al. Novel TRPM8 antagonist attenuates cold 
hypersensitivity after peripheral nerve injury in rats. The Journal of Pharmacology and 
Experimental Therapeutics 2014; 349(1): 47-55. 
81. Wasner G, Naleschinski D, Binder A, Schattschneider J, McLachlan EM, Baron R. 
The effect of menthol on cold allodynia in patients with neuropathic pain. Pain Medicine 
2008; 9(3): 354-8. 
82. Wright A. Oil of peppermint as a local anaesthetic. The Lancet 1870; 2464: 726. 
83. Green BG, McAuliffe BL. Menthol desensitization of capsaicin irritation. Evidence of 
a short-term anti-nociceptive effect. Physiology & Behavior 2000; 68(5): 631-9. 
84. Davies SJ, Harding LM, Baranowski AP. A novel treatment of postherpetic neuralgia 
using peppermint oil. The Clinical Journal of Pain 2002; 18(3): 200-2. 
85. Galeotti N, Di Cesare Mannelli L, Mazzanti G, Bartolini A, Ghelardini C. Menthol: a 
natural analgesic compound. Neuroscience Letters 2002; 322(3): 145-8. 
86. Klein AH, Sawyer CM, Carstens MI, Tsagareli MG, Tsiklauri N, Carstens E. Topical 
application of L-menthol induces heat analgesia, mechanical allodynia, and a biphasic effect 
on cold sensitivity in rats. Behavioural Brain Research 2010; 212(2): 179-86. 
87. Hagenacker T, Lampe M, Schafers M. Icilin reduces voltage-gated calcium channel 
currents in naive and injured DRG neurons in the rat spinal nerve ligation model. Brain 
Research 2014; 1557: 171-9. 
88. Katsura H, Obata K, Mizushima T, et al. Antisense knock down of TRPA1, but not 
TRPM8, alleviates cold hyperalgesia after spinal nerve ligation in rats. Experimental 
Neurology 2006; 200(1): 112-23. 
89. Liu B, Fan L, Balakrishna S, Sui A, Morris JB, Jordt SE. TRPM8 is the principal 
mediator of menthol-induced analgesia of acute and inflammatory pain. Pain 2013; 154(10): 
2169-77. 
90. Pan R, Tian Y, Gao R, et al. Central mechanisms of menthol-induced analgesia. The 
Journal of Pharmacology and Experimental Therapeutics 2012; 343(3): 661-72. 
91. Vinuela-Fernandez I, Sun L, Jerina H, et al. The TRPM8 channel forms a complex 
with the 5-HT(1B) receptor and phospholipase D that amplifies its reversal of pain 
hypersensitivity. Neuropharmacology 2014; 79: 136-51. 
92. Colvin LA, Johnson PR, Mitchell R, Fleetwood-Walker SM, Fallon M. From bench to 
bedside: a case of rapid reversal of bortezomib-induced neuropathic pain by the TRPM8 
activator, menthol. J Clin Oncol 2008; 26(27): 4519-20. 
93. Storey DJ, Colvin LA, Mackean MJ, Mitchell R, Fleetwood-Walker SM, Fallon MT. 
Reversal of dose-limiting carboplatin-induced peripheral neuropathy with TRPM8 activator, 
menthol, enables further effective chemotherapy delivery. Journal of Pain and Symptom 
Management 2010; 39(6): e2-4. 
94. Gavva NR, Bannon AW, Surapaneni S, et al. The vanilloid receptor TRPV1 is 
tonically activated in vivo and involved in body temperature regulation. J Neurosci 2007; 
27(13): 3366-74. 
95. Steiner AA, Turek VF, Almeida MC, et al. Nonthermal activation of transient 
receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic 
cold-defense effectors. J Neurosci 2007; 27(28): 7459-68. 
96. Wei ET. Pharmacological aspects of shaking behavior produced by TRH, AG-3-5, 
and morphine withdrawal. Fed Proc 1981; 40(5): 1491-6. 
97. Werkheiser J, Cowan A, Gomez T, et al. Icilin-induced wet-dog shakes in rats are 
dependent on NMDA receptor activation and nitric oxide production. Pharmacol Biochem 
Behav 2009; 92(3): 543-8. 
98. Almeida MC, Steiner AA, Branco LG, Romanovsky AA. Cold-seeking behavior as a 
thermoregulatory strategy in systemic inflammation. The European Journal of Neuroscience 
2006; 23(12): 3359-67. 
99. Ruskin DN, Anand R, LaHoste GJ. Menthol and nicotine oppositely modulate body 
temperature in the rat. European Journal of Pharmacology 2007; 559(2-3): 161-4. 
100. Tajino K, Matsumura K, Kosada K, et al. Application of menthol to the skin of whole 
trunk in mice induces autonomic and behavioral heat-gain responses. American Journal of 
Physiology 2007; 293(5): R2128-35. 
101. Ding Z, Gomez T, Werkheiser JL, Cowan A, Rawls SM. Icilin induces a 
hyperthermia in rats that is dependent on nitric oxide production and NMDA receptor 
activation. European Journal of Pharmacology 2008; 578(2-3): 201-8. 
102. Tajino K, Hosokawa H, Maegawa S, Matsumura K, Dhaka A, Kobayashi S. Cooling-
sensitive TRPM8 is thermostat of skin temperature against cooling. PLoS One 2011; 6(3): 
e17504. 
103. Almeida MC, Hew-Butler T, Soriano RN, et al. Pharmacological blockade of the cold 
receptor TRPM8 attenuates autonomic and behavioral cold defenses and decreases deep body 
temperature. J Neurosci 2012; 32(6): 2086-99. 
104. Gavva NR, Davis C, Lehto SG, Rao S, Wang W, Zhu DX. Transient receptor 
potential melastatin 8 (TRPM8) channels are involved in body temperature regulation. 
Molecular Pain 2012; 8: 36. 
105. Behrendt HJ, Germann T, Gillen C, Hatt H, Jostock R. Characterization of the mouse 
cold-menthol receptor TRPM8 and vanilloid receptor type-1 VR1 using a fluorometric 
imaging plate reader (FLIPR) assay. British Journal of Pharmacology 2004; 141(4): 737-45. 
106. Weil A, Moore SE, Waite NJ, Randall A, Gunthorpe MJ. Conservation of functional 
and pharmacological properties in the distantly related temperature sensors TRVP1 and 
TRPM8. Molecular Pharmacology 2005; 68(2): 518-27. 
107. Meseguer V, Karashima Y, Talavera K, et al. Transient receptor potential channels in 
sensory neurons are targets of the antimycotic agent clotrimazole. J Neurosci 2008; 28(3): 
576-86. 
108. DeFalco J, Steiger D, Dourado M, Emerling D, Duncton MA. 5-benzyloxytryptamine 
as an antagonist of TRPM8. Bioorg Med Chem Lett 2010; 20(23): 7076-9. 
109. Lashinger ES, Steiginga MS, Hieble JP, et al. AMTB, a TRPM8 channel blocker: 
evidence in rats for activity in overactive bladder and painful bladder syndrome. American 
Journal of Physiology Renal Physiology 2008; 295(3): F803-10. 
110. Branum ST, Colburn RW, Dax SL, et al. N-benzothienyl sulfonamides as TRPM8 
modulators and their preparation,pharmaceutical compositions and use in the treatment of 
diseases. Chem Abstr 2009; 150: 168153. 
111. Irlapati NR, Thomas AL, Kurhe DK, et al. Preparation of fused oxazole and thiazole 
derivatives as TRPM8 modulators. Chem Abstr 2010; 152: 192106. 
112. Ortar G, De Petrocellis L, Morera L, et al. (-)-Menthylamine derivatives as potent and 
selective antagonists of transient receptor potential melastatin type-8 (TRPM8) channels. 
Bioorg Med Chem Lett 2010; 20(9): 2729-32. 
113. Parks DJ, Parsons WH, Colburn RW, et al. Design and optimization of 
benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonists. J 
Med Chem 2011; 54(1): 233-47. 
114. Calvo RR, Meegalla SK, Parks DJ, et al. Discovery of vinylcycloalkyl-substituted 
benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia. Bioorg Med 
Chem Lett 2012; 22(5): 1903-7. 
115. Matthews JM, Qin N, Colburn RW, et al. The design and synthesis of novel, 
phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists. 
Bioorg Med Chem Lett 2012; 22(8): 2922-6. 
116. Tamayo NA, Bo Y, Gore V, et al. Fused piperidines as a novel class of potent and 
orally available transient receptor potential melastatin type 8 (TRPM8) antagonists. J Med 
Chem 2012; 55(4): 1593-611. 
117. Ortar G, Schiano Moriello A, Morera E, Nalli M, Di Marzo V, De Petrocellis L. 3-
Ylidenephthalides as a new class of transient receptor potential channel TRPA1 and TRPM8 
modulators. Bioorg Med Chem Lett 2013; 23(20): 5614-8. 
118. Zhu B, Xia M, Xu X, et al. Arylglycine derivatives as potent transient receptor 
potential melastatin 8 (TRPM8) antagonists. Bioorg Med Chem Lett 2013; 23(7): 2234-7. 
119. De Petrocellis L, Starowicz K, Moriello AS, Vivese M, Orlando P, Di Marzo V. 
Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of 
cAMP, cannabinoid CB(1) receptors and endovanilloids. Experimental Cell Research 2007; 
313(9): 1911-20. 
120. Beck B, Bidaux G, Bavencoffe A, et al. Prospects for prostate cancer imaging and 
therapy using high-affinity TRPM8 activators. Cell Calcium 2007; 41(3): 285-94. 
121. Bodding M, Wissenbach U, Flockerzi V. Characterisation of TRPM8 as a 
pharmacophore receptor. Cell Calcium 2007; 42(6): 618-28. 
122. Duncan DF, Stewart F, Frolich MW, Urdeal D. Preclinical evaluation of the TRPM8 
ion channel agonist D-3263 for benign prostatic hyperplasia. J Urol 2009; 181(4): 503. 
123. Sherkheli MA, Vogt-Eisele AK, Bura D, Beltran Marques LR, Gisselmann G, Hatt H. 
Characterization of selective TRPM8 ligands and their structure activity response (S.A.R) 
relationship. Journal of Pharmacy & Pharmaceutical Sciences 2010; 13(2): 242-53. 
124. Bharate SS, Bharate SB. Modulation of thermoreceptor TRPM8 by cooling 
compounds. ACS Chem Neurosci 2012; 3(4): 248-67. 
125. Journigan VB, Zaveri NT. TRPM8 ion channel ligands for new therapeutic 
applications and as probes to study menthol pharmacology. Life Sci 2013; 92(8-9): 425-37. 
126. Wei ET, Seid DA. AG-3-5: a chemical producing sensations of cold. The Journal of 
Pharmacy and Pharmacology 1983; 35(2): 110-2. 
127. Sherkheli MA, Gisselmann G, Hatt H. Supercooling agent icilin blocks a warmth-
sensing ion channel TRPV3. The Scientific World Journal 2012; 2012: 982725. 
128. Ostacolo C, Ambrosino P, Russo R, et al. Isoxazole derivatives as potent transient 
receptor potential melastatin type 8 (TRPM8) agonists. European Journal of Medicinal 
Chemistry 2013; 69: 659-69. 
129. Pedretti A, Marconi C, Bettinelli I, Vistoli G. Comparative modeling of the 
quaternary structure for the human TRPM8 channel and analysis of its binding features. 
Biochimica et Biophysica Acta 2009; 1788(5): 973-82. 
130. Swandulla D, Carbone E, Schafer K, Lux HD. Effect of menthol on two types of Ca 
currents in cultured sensory neurons of vertebrates. Pflugers Arch 1987; 409(1-2): 52-9. 
131. Haeseler G, Maue D, Grosskreutz J, et al. Voltage-dependent block of neuronal and 
skeletal muscle sodium channels by thymol and menthol. European Journal of 
Anaesthesiology 2002; 19(8): 571-9. 
132. Hall AC, Turcotte CM, Betts BA, Yeung WY, Agyeman AS, Burk LA. Modulation of 
human GABAA and glycine receptor currents by menthol and related monoterpenoids. 
European Journal of Pharmacology 2004; 506(1): 9-16. 
133. Watt EE, Betts BA, Kotey FO, et al. Menthol shares general anesthetic activity and 
sites of action on the GABA(A) receptor with the intravenous agent, propofol. European 
Journal of Pharmacology 2008; 590(1-3): 120-6. 
134. Zhang XB, Jiang P, Gong N, et al. A-type GABA receptor as a central target of 
TRPM8 agonist menthol. PLoS One 2008; 3(10): e3386. 
135. Sherkheli MA, Benecke H, Doerner JF, et al. Monoterpenoids induce agonist-specific 
desensitization of transient receptor potential vanilloid-3 (TRPV3) ion channels. Journal of 
Pharmacy & Pharmaceutical Sciences 2009; 12(1): 116-28. 
136. Baylie RL, Cheng H, Langton PD, James AF. Inhibition of the cardiac L-type calcium 
channel current by the TRPM8 agonist, (-)-menthol. Journal of Physiology and 
Pharmacology 2010; 61(5): 543-50. 
137. Gaudioso C, Hao J, Martin-Eauclaire MF, Gabriac M, Delmas P. Menthol pain relief 
through cumulative inactivation of voltage-gated sodium channels. Pain 2012; 153(2): 473-
84. 
138. Hans M, Wilhelm M, Swandulla D. Menthol suppresses nicotinic acetylcholine 
receptor functioning in sensory neurons via allosteric modulation. Chemical Senses 2012; 
37(5): 463-9. 
139. Kim SH, Lee S, Piccolo SR, et al. Menthol induces cell-cycle arrest in PC-3 cells by 
down-regulating G2/M genes, including polo-like kinase 1. Biochemical and Biophysical 
Research Communications 2012; 422(3): 436-41. 
140. Ashoor A, Nordman JC, Veltri D, et al. Menthol binding and inhibition of alpha7-
nicotinic acetylcholine receptors. PLoS One 2013; 8(7): e67674. 
141. Kawasaki H, Mizuta K, Fujita T, Kumamoto E. Inhibition by menthol and its related 
chemicals of compound action potentials in frog sciatic nerves. Life Sci 2013; 92(6-7): 359-
67. 
142. Lau BK, Karim S, Goodchild AK, Vaughan CW, Drew GM. Menthol enhances 
phasic and tonic GABAA receptor-mediated currents in midbrain periaqueductal grey 
neurons. British Journal of Pharmacology 2014; 171(11): 2803-13. 
143. Walstab J, Wohlfarth C, Hovius R, et al. Natural compounds boldine and menthol are 
antagonists of human 5-HT receptors: implications for treating gastrointestinal disorders. 
Neurogastroenterology and Motility 2014; 26(6): 810-20. 
144. Yamamura H, Ugawa S, Ueda T, Nagao M, Shimada S. Icilin activates the delta-
subunit of the human epithelial Na+ channel. Molecular Pharmacology 2005; 68(4): 1142-7. 
145. Kim SH, Kim SY, Park EJ, et al. Icilin induces G1 arrest through activating JNK and 
p38 kinase in a TRPM8-independent manner. Biochemical and Biophysical Research 
Communications 2011; 406(1): 30-5. 
146. Lee S, Chun JN, Kim SH, So I, Jeon JH. Icilin inhibits E2F1-mediated cell cycle 
regulatory programs in prostate cancer. Biochemical and Biophysical Research 
Communications 2013; 441(4): 1005-10. 
147. Liu B, Qin F. Functional control of cold- and menthol-sensitive TRPM8 ion channels 
by phosphatidylinositol 4,5-bisphosphate. J Neurosci 2005; 25(7): 1674-81. 
148. Rohacs T, Lopes CM, Michailidis I, Logothetis DE. PI(4,5)P2 regulates the activation 
and desensitization of TRPM8 channels through the TRP domain. Nature Neuroscience 2005; 
8(5): 626-34. 
149. Zakharian E, Cao C, Rohacs T. Gating of transient receptor potential melastatin 8 
(TRPM8) channels activated by cold and chemical agonists in planar lipid bilayers. J 
Neurosci 2010; 30(37): 12526-34. 
150. Daniels RL, Takashima Y, McKemy DD. Activity of the neuronal cold sensor 
TRPM8 is regulated by phospholipase C via the phospholipid phosphoinositol 4,5-
bisphosphate. The Journal of Biological Chemistry 2009; 284(3): 1570-82. 
151. Yudin Y, Lukacs V, Cao C, Rohacs T. Decrease in phosphatidylinositol 4,5-
bisphosphate levels mediates desensitization of the cold sensor TRPM8 channels. The 
Journal of Physiology 2011; 589(Pt 24): 6007-27. 
152. Tang Z, Kim A, Masuch T, et al. Pirt functions as an endogenous regulator of 
TRPM8. Nat Commun 2013; 4: 2179. 
153. Vanden Abeele F, Zholos A, Bidaux G, et al. Ca2+-independent phospholipase A2-
dependent gating of TRPM8 by lysophospholipids. The Journal of Biological Chemistry 
2006; 281(52): 40174-82. 
154. Andersson DA, Nash M, Bevan S. Modulation of the cold-activated channel TRPM8 
by lysophospholipids and polyunsaturated fatty acids. J Neurosci 2007; 27(12): 3347-55. 
155. Bavencoffe A, Kondratskyi A, Gkika D, et al. Complex regulation of the TRPM8 cold 
receptor channel: role of arachidonic acid release following M3 muscarinic receptor 
stimulation. The Journal of Biological Chemistry 2011; 286(11): 9849-55. 
156. Morenilla-Palao C, Pertusa M, Meseguer V, Cabedo H, Viana F. Lipid raft 
segregation modulates TRPM8 channel activity. The Journal of Biological Chemistry 2009; 
284(14): 9215-24. 
157. Vanden Abeele F, Kondratskyi A, Dubois C, et al. Complex modulation of the cold 
receptor TRPM8 by volatile anaesthetics and its role in complications of general anaesthesia. 
Journal of Cell Science 2013; 126(Pt 19): 4479-89. 
158. Latorre R, Brauchi S, Orta G, Zaelzer C, Vargas G. ThermoTRP channels as modular 
proteins with allosteric gating. Cell Calcium 2007; 42(4-5): 427-38. 
159. Premkumar LS, Raisinghani M, Pingle SC, Long C, Pimentel F. Downregulation of 
transient receptor potential melastatin 8 by protein kinase C-mediated dephosphorylation. J 
Neurosci 2005; 25(49): 11322-9. 
160. Abe J, Hosokawa H, Sawada Y, Matsumura K, Kobayashi S. Ca2+-dependent PKC 
activation mediates menthol-induced desensitization of transient receptor potential M8. 
Neuroscience Letters 2006; 397(1-2): 140-4. 
161. Linte RM, Ciobanu C, Reid G, Babes A. Desensitization of cold- and menthol-
sensitive rat dorsal root ganglion neurones by inflammatory mediators. Experimental Brain 
Research 2007; 178(1): 89-98. 
162. Sarria I, Gu J. Menthol response and adaptation in nociceptive-like and 
nonnociceptive-like neurons: role of protein kinases. Molecular Pain 2010; 6: 47. 
163. Bavencoffe A, Gkika D, Kondratskyi A, et al. The transient receptor potential channel 
TRPM8 is inhibited via the alpha 2A adrenoreceptor signaling pathway. The Journal of 
Biological Chemistry 2010; 285(13): 9410-9. 
164. Babes A, Zorzon D, Reid G. Two populations of cold-sensitive neurons in rat dorsal 
root ganglia and their modulation by nerve growth factor. The European Journal of 
Neuroscience 2004; 20(9): 2276-82. 
165. Takashima Y, Ma L, McKemy DD. The development of peripheral cold neural 
circuits based on TRPM8 expression. Neuroscience 2010; 169(2): 828-42. 
166. Lippoldt EK, Elmes RR, McCoy DD, Knowlton WM, McKemy DD. Artemin, a glial 
cell line-derived neurotrophic factor family member, induces TRPM8-dependent cold pain. 
The Journal of Neuroscience 2013; 33(30): 12543-52. 
167. Zhang X, Mak S, Li L, et al. Direct inhibition of the cold-activated TRPM8 ion 
channel by Galpha(q). Nat Cell Biol 2012; 14(8): 851-8. 
168. Carman CV, Parent JL, Day PW, et al. Selective regulation of Galpha(q/11) by an 
RGS domain in the G protein-coupled receptor kinase, GRK2. The Journal of Biological 
Chemistry 1999; 274(48): 34483-92. 
169. Tesmer VM, Kawano T, Shankaranarayanan A, Kozasa T, Tesmer JJ. Snapshot of 
activated G proteins at the membrane: the Galphaq-GRK2-Gbetagamma complex. Science 
(New York, NY 2005; 310(5754): 1686-90. 
170. Li L, Zhang X. Differential inhibition of the TRPM8 ion channel by Galphaq and 
Galpha 11. Channels 2013; 7(2): 115-8. 
171. Day PW, Carman CV, Sterne-Marr R, Benovic JL, Wedegaertner PB. Differential 
interaction of GRK2 with members of the G alpha q family. Biochemistry 2003; 42(30): 
9176-84. 
172. Chuang HH, Prescott ED, Kong H, et al. Bradykinin and nerve growth factor release 
the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 2001; 411(6840): 957-
62. 
173. Than JY, Li L, Hasan R, Zhang X. Excitation and modulation of TRPA1, TRPV1, and 
TRPM8 channel-expressing sensory neurons by the pruritogen chloroquine. The Journal of 
Biological Chemistry 2013; 288(18): 12818-27. 
174. Klasen K, Hollatz D, Zielke S, Gisselmann G, Hatt H, Wetzel CH. The TRPM8 ion 
channel comprises direct Gq protein-activating capacity. Pflugers Archiv 2012; 463(6): 779-
97. 
175. Mahieu F, Owsianik G, Verbert L, et al. TRPM8-independent menthol-induced Ca2+ 
release from endoplasmic reticulum and Golgi. The Journal of Biological Chemistry 2007; 
282(5): 3325-36. 
176. Christensen BN, Perl ER. Spinal neurons specifically excited by noxious or thermal 
stimuli: marginal zone of the dorsal horn. Journal of Neurophysiology 1970; 33(2): 293-307. 
177. Dostrovsky JO, Craig AD. Cooling-specific spinothalamic neurons in the monkey. 
Journal of Neurophysiology 1996; 76(6): 3656-65. 
178. Han ZS, Zhang ET, Craig AD. Nociceptive and thermoreceptive lamina I neurons are 
anatomically distinct. Nature Neuroscience 1998; 1(3): 218-25. 
179. Craig AD, Krout K, Andrew D. Quantitative response characteristics of 
thermoreceptive and nociceptive lamina I spinothalamic neurons in the cat. Journal of 
Neurophysiology 2001; 86(3): 1459-80. 
180. Suzuki SC, Furue H, Koga K, et al. Cadherin-8 is required for the first relay synapses 
to receive functional inputs from primary sensory afferents for cold sensation. The Journal of 
Neuroscience 2007; 27(13): 3466-76. 
181. Kim YS, Park JH, Choi SJ, et al. Central connectivity of transient receptor potential 
melastatin 8-expressing axons in the brain stem and spinal dorsal horn. PLoS One 2014; 9(4): 
e94080. 
182. Hantman AW, Perl ER. Molecular and genetic features of a labeled class of spinal 
substantia gelatinosa neurons in a transgenic mouse. The Journal of Comparative Neurology 
2005; 492(1): 90-100. 
183. Zheng J, Lu Y, Perl ER. Inhibitory neurones of the spinal substantia gelatinosa 
mediate interaction of signals from primary afferents. The Journal of Physiology 2010; 
588(Pt 12): 2065-75. 
184. Yasaka T, Kato G, Furue H, et al. Cell-type-specific excitatory and inhibitory circuits 
involving primary afferents in the substantia gelatinosa of the rat spinal dorsal horn in vitro. 
The Journal of Physiology 2007; 581(Pt 2): 603-18. 
185. Todd AJ. Neuronal circuitry for pain processing in the dorsal horn. Nature Reviews 
Neuroscience 2010; 11(12): 823-36. 
186. Ross SE, Mardinly AR, McCord AE, et al. Loss of inhibitory interneurons in the 
dorsal spinal cord and elevated itch in Bhlhb5 mutant mice. Neuron 2010; 65(6): 886-98. 
187. Kardon AP, Polgar E, Hachisuka J, et al. Dynorphin acts as a neuromodulator to 
inhibit itch in the dorsal horn of the spinal cord. Neuron 2014; 82(3): 573-86. 
188. Shapovalov G, Gkika D, Devilliers M, et al. Opiates modulate thermosensation by 
internalizing cold receptor TRPM8. Cell Rep 2013; 4(3): 504-15. 
189. McCoy ES, Taylor-Blake B, Street SE, Pribisko AL, Zheng J, Zylka MJ. Peptidergic 
CGRPalpha primary sensory neurons encode heat and itch and tonically suppress sensitivity 















as % TRPV1 
Colocalised 




















Immunofluorescence assessment of TRPV1/TRPM8 colocalisation in small DRG neurons: Sixteen 
µm unfixed cryostat sections (12-19 from 4-5 rats in each case) were incubated with guinea pig anti-
TRPV1 and rabbit anti-TRPM8 primary antibodies, then appropriate secondaries labelled with distinct 
ALEXA-fluorophores. Cells were counted at x40 magnification from confocal images using a Zeiss 
LS510 Axiovert microscope. 
 
  
Figure 1.  Examples of recently produced TRPM8 antagonists reported to be active at 
submicromolar concentrations in vitro. Compounds represent several distinct structural 
series. While certainly potent TRPM8 antagonists, the pharmacological selectivity profiles 




Figure 2.  TRPM8 agonists of different structural series. WS-12 and D-3263 are analogues of 
menthol with considerably increased potency, showing EC50 at submicromolar 
concentrations. D-3263 has undergone a Phase 1, Open Label Trial in relation to potential 
anti-tumour activity. Icilin shows submicromolar potency and moderate selectivity. 




Figure 3.  Schematic diagram illustrating the analgesic gating-out of hypersensitive spinal 
nociceptive transmission in chronic pain by TRPM8-expressing non-nociceptive afferents 
and the molecular mechanism through which 5-HT1B receptors act to enhance this process.  
 
